A stroma szerepe a daganatok biológiai viselkedésében

Translated title of the contribution: Role of stroma in the neoplastic growth

T. Füle, Baghy Kornélia, P. Tátrai, Péterfia Bálint, I. Kovalszky

Research output: Contribution to journalArticle

Abstract

For a long time scientists involved in cancer research have focused their attention on cancer cells, neglecting other components of tumorous tissue. By now it became evident that stromal elements have a tremendous impact on the nature of cancer. The tumor stroma contains fibroblasts, endothelial cells of blood vessels and inflammatory cells. They maintain an active cross-talk with the tumor cells via regulatory factors, embedded in the extracellular matrix, a substance built up mainly by glycoproteins. At the beginning of tumor development the stroma exerts a protective action against tumor growth. However, its phenotype gradually changes ending up with the state of "primed stroma" which supports tumorous growth. This is characterized by activated myofibroblasts producing matrix proteins in increased quantity and of altered quality. This matrix is rich in proteoglycans acting as growth factor reservoirs, or coreceptors for stimulatory signal transduction on the tumor cell surface. Other matrix proteins interact with integrin receptors of cancer cells. Triptic fragments of matrix proteins can increase or inhibit angiogenesis, which is a critical requirement for tumor growth. Recently, it was evidenced that tumor-associated fibroblasts contain genetic alterations, which also act toward the progression of the tumor. In the light of these new data, stroma is increasingly emerging as an alternative therapeutic target.

Original languageHungarian
Pages (from-to)193-197
Number of pages5
JournalOrvoskepzes
Volume81
Issue number3
Publication statusPublished - 2006

Fingerprint

Growth
Neoplasms
Proteins
Myofibroblasts
Proteoglycans
Integrins
Extracellular Matrix
Blood Vessels
Signal Transduction
Intercellular Signaling Peptides and Proteins
Glycoproteins
Endothelial Cells
Fibroblasts
Phenotype
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A stroma szerepe a daganatok biológiai viselkedésében. / Füle, T.; Kornélia, Baghy; Tátrai, P.; Bálint, Péterfia; Kovalszky, I.

In: Orvoskepzes, Vol. 81, No. 3, 2006, p. 193-197.

Research output: Contribution to journalArticle

Füle, T. ; Kornélia, Baghy ; Tátrai, P. ; Bálint, Péterfia ; Kovalszky, I. / A stroma szerepe a daganatok biológiai viselkedésében. In: Orvoskepzes. 2006 ; Vol. 81, No. 3. pp. 193-197.
@article{ed041779b78949a5b302bed844b82ce9,
title = "A stroma szerepe a daganatok biol{\'o}giai viselked{\'e}s{\'e}ben",
abstract = "For a long time scientists involved in cancer research have focused their attention on cancer cells, neglecting other components of tumorous tissue. By now it became evident that stromal elements have a tremendous impact on the nature of cancer. The tumor stroma contains fibroblasts, endothelial cells of blood vessels and inflammatory cells. They maintain an active cross-talk with the tumor cells via regulatory factors, embedded in the extracellular matrix, a substance built up mainly by glycoproteins. At the beginning of tumor development the stroma exerts a protective action against tumor growth. However, its phenotype gradually changes ending up with the state of {"}primed stroma{"} which supports tumorous growth. This is characterized by activated myofibroblasts producing matrix proteins in increased quantity and of altered quality. This matrix is rich in proteoglycans acting as growth factor reservoirs, or coreceptors for stimulatory signal transduction on the tumor cell surface. Other matrix proteins interact with integrin receptors of cancer cells. Triptic fragments of matrix proteins can increase or inhibit angiogenesis, which is a critical requirement for tumor growth. Recently, it was evidenced that tumor-associated fibroblasts contain genetic alterations, which also act toward the progression of the tumor. In the light of these new data, stroma is increasingly emerging as an alternative therapeutic target.",
keywords = "Cancer, Stroma, Therapy",
author = "T. F{\"u}le and Baghy Korn{\'e}lia and P. T{\'a}trai and P{\'e}terfia B{\'a}lint and I. Kovalszky",
year = "2006",
language = "Hungarian",
volume = "81",
pages = "193--197",
journal = "Orvoskepzes",
issn = "0030-6037",
publisher = "Semmelweis Kiado",
number = "3",

}

TY - JOUR

T1 - A stroma szerepe a daganatok biológiai viselkedésében

AU - Füle, T.

AU - Kornélia, Baghy

AU - Tátrai, P.

AU - Bálint, Péterfia

AU - Kovalszky, I.

PY - 2006

Y1 - 2006

N2 - For a long time scientists involved in cancer research have focused their attention on cancer cells, neglecting other components of tumorous tissue. By now it became evident that stromal elements have a tremendous impact on the nature of cancer. The tumor stroma contains fibroblasts, endothelial cells of blood vessels and inflammatory cells. They maintain an active cross-talk with the tumor cells via regulatory factors, embedded in the extracellular matrix, a substance built up mainly by glycoproteins. At the beginning of tumor development the stroma exerts a protective action against tumor growth. However, its phenotype gradually changes ending up with the state of "primed stroma" which supports tumorous growth. This is characterized by activated myofibroblasts producing matrix proteins in increased quantity and of altered quality. This matrix is rich in proteoglycans acting as growth factor reservoirs, or coreceptors for stimulatory signal transduction on the tumor cell surface. Other matrix proteins interact with integrin receptors of cancer cells. Triptic fragments of matrix proteins can increase or inhibit angiogenesis, which is a critical requirement for tumor growth. Recently, it was evidenced that tumor-associated fibroblasts contain genetic alterations, which also act toward the progression of the tumor. In the light of these new data, stroma is increasingly emerging as an alternative therapeutic target.

AB - For a long time scientists involved in cancer research have focused their attention on cancer cells, neglecting other components of tumorous tissue. By now it became evident that stromal elements have a tremendous impact on the nature of cancer. The tumor stroma contains fibroblasts, endothelial cells of blood vessels and inflammatory cells. They maintain an active cross-talk with the tumor cells via regulatory factors, embedded in the extracellular matrix, a substance built up mainly by glycoproteins. At the beginning of tumor development the stroma exerts a protective action against tumor growth. However, its phenotype gradually changes ending up with the state of "primed stroma" which supports tumorous growth. This is characterized by activated myofibroblasts producing matrix proteins in increased quantity and of altered quality. This matrix is rich in proteoglycans acting as growth factor reservoirs, or coreceptors for stimulatory signal transduction on the tumor cell surface. Other matrix proteins interact with integrin receptors of cancer cells. Triptic fragments of matrix proteins can increase or inhibit angiogenesis, which is a critical requirement for tumor growth. Recently, it was evidenced that tumor-associated fibroblasts contain genetic alterations, which also act toward the progression of the tumor. In the light of these new data, stroma is increasingly emerging as an alternative therapeutic target.

KW - Cancer

KW - Stroma

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=35648995814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648995814&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:35648995814

VL - 81

SP - 193

EP - 197

JO - Orvoskepzes

JF - Orvoskepzes

SN - 0030-6037

IS - 3

ER -